[END CALLOUT BOX] GLP2 Research Applications & Key Findings Type 2 Diabetes Management SURPASS Clinical Trial Program The SURPASS phase 3 clinical program enrolled over 6,000 participants across five global registration trials, evaluating GLP2 across the type 2 diabetes treatment continuum
Simply put, these medications do the following: Stimulate the pancreas to release more insulin when blood sugar is high
In the adjusted cause-specific-hazard regression for the GLP-1 RA vs DPP-4 inhibitor cohort, GLP-1 RAs were associated with a lower risk of suicide or suicide attempts compared with DPP-4 inhibitors after 1 year follow-up (HR 365 0.58 [0.37;0.91])
406 Therefore, endogenous GLP-1R signaling in astrocytes plays a critical role in maintaining mitochondrial homeostasis and is dependent on FGF21 to effectively regulate glucose metabolism
Microdosing is considered off-label use and its not clear whether its safe or effective, since it hasnt gone through same testing
Exendin-4, a glucagon-like peptide 1 receptor agonist, protects against amyloid-beta peptide-induced impairment of spatial learning and memory in rats